Vor Biopharma Inc. (VOR) Tops Q2 EPS by 1c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q2 EPS of ($0.41), $0.01 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Supreme Court rules against order limiting birthright citizenship